$HAE
HAEMONETICS CORP

2020 Q1 Form 10-Q Financial Statement

#000031314320000012 Filed on February 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2018 Q4
Revenue $238.5M $259.0M $247.4M
YoY Change -4.33% 4.7% 5.69%
Cost Of Revenue $124.9M $130.9M $136.2M
YoY Change -9.56% -3.86% 10.94%
Gross Profit $113.6M $128.1M $111.2M
YoY Change 2.11% 15.18% -0.11%
Gross Profit Margin 47.61% 49.45% 44.95%
Selling, General & Admin $79.40M $78.27M $73.88M
YoY Change 9.97% 5.94% -24.5%
% of Gross Profit 69.92% 61.12% 66.45%
Research & Development $9.000M $7.000M $8.978M
YoY Change 3.45% -22.03% -27.75%
% of Gross Profit 7.93% 5.47% 8.08%
Depreciation & Amortization $28.80M $27.00M $27.90M
YoY Change -3.36% -3.23% 25.11%
% of Gross Profit 25.36% 21.09% 25.1%
Operating Expenses $88.40M $87.14M $82.86M
YoY Change 9.27% 5.18% -24.87%
Operating Profit $26.01M $40.91M $28.32M
YoY Change 9.02% 44.45% 2695.66%
Interest Expense -$4.000M -$3.100M -$2.900M
YoY Change 100.0% 6.9% 262.5%
% of Operating Profit -15.38% -7.58% -10.24%
Other Income/Expense, Net -$3.078M -$2.858M
YoY Change 7.7% 254.59%
Pretax Income $22.00M $37.83M $25.46M
YoY Change 0.92% 48.57% 12200.48%
Income Tax $4.300M $7.900M $7.200M
% Of Pretax Income 19.55% 20.88% 28.28%
Net Earnings $17.62M $29.90M -$8.479M
YoY Change -15.41% -452.58% 29.51%
Net Earnings / Revenue 7.39% 11.54% -3.43%
Basic Earnings Per Share $0.35 $0.59 $0.36
Diluted Earnings Per Share $0.34 $0.58 $0.35
COMMON SHARES
Basic Shares Outstanding 50.30M shares 50.63M shares 51.40M shares
Diluted Shares Outstanding 51.64M shares 52.82M shares

Balance Sheet

Concept 2020 Q1 2019 Q4 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.3M $126.4M $154.9M
YoY Change -18.95% -18.4% -38.43%
Cash & Equivalents $137.3M $126.4M $154.9M
Short-Term Investments
Other Short-Term Assets $30.80M $31.20M $24.50M
YoY Change 12.41% 27.35% -24.62%
Inventory $270.3M $254.2M $168.9M
Prepaid Expenses
Receivables $165.2M $170.8M $167.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $603.6M $582.6M $515.9M
YoY Change 4.78% 12.92% -12.52%
LONG-TERM ASSETS
Property, Plant & Equipment $253.4M $268.1M $351.1M
YoY Change -26.33% -23.64% 6.39%
Goodwill $210.7M $211.1M $210.7M
YoY Change -0.08% 0.16% -0.17%
Intangibles $133.1M
YoY Change 4.24%
Long-Term Investments
YoY Change
Other Assets $62.38M $64.27M $11.48M
YoY Change 428.86% 459.72% -7.64%
Total Long-Term Assets $663.5M $655.2M $711.7M
YoY Change -5.03% -7.95% -1.42%
TOTAL ASSETS
Total Short-Term Assets $603.6M $582.6M $515.9M
Total Long-Term Assets $663.5M $655.2M $711.7M
Total Assets $1.267B $1.238B $1.228B
YoY Change -0.6% 0.82% -6.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.73M $52.30M $62.58M
YoY Change -19.93% -16.43% 50.81%
Accrued Expenses $56.80M $50.40M $51.80M
YoY Change 6.77% -2.7% -17.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $76.98M $61.97M $17.20M
YoY Change 178.25% 260.29% -88.64%
Total Short-Term Liabilities $274.8M $256.7M $211.3M
YoY Change 16.57% 21.49% -34.83%
LONG-TERM LIABILITIES
Long-Term Debt $305.5M $309.7M $326.6M
YoY Change -5.25% -5.17% 175.16%
Other Long-Term Liabilities $89.10M $82.16M $28.17M
YoY Change 209.6% 191.7% -28.87%
Total Long-Term Liabilities $394.6M $391.9M $354.8M
YoY Change 12.35% 10.46% 124.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $274.8M $256.7M $211.3M
Total Long-Term Liabilities $394.6M $391.9M $354.8M
Total Liabilities $669.4M $648.6M $566.1M
YoY Change 14.05% 14.58% 17.32%
SHAREHOLDERS EQUITY
Retained Earnings $78.51M $69.87M $140.6M
YoY Change -51.36% -50.3% -56.56%
Common Stock $553.7M $538.4M $531.6M
YoY Change 3.15% 1.27% 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $587.1M $574.6M $591.0M
YoY Change
Total Liabilities & Shareholders Equity $1.267B $1.238B $1.228B
YoY Change -0.6% 0.82% -6.41%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2018 Q4
OPERATING ACTIVITIES
Net Income $17.62M $29.90M -$8.479M
YoY Change -15.41% -452.58% 29.51%
Depreciation, Depletion And Amortization $28.80M $27.00M $27.90M
YoY Change -3.36% -3.23% 25.11%
Cash From Operating Activities $46.40M $79.30M $58.10M
YoY Change 124.15% 36.49% -11.16%
INVESTING ACTIVITIES
Capital Expenditures -$10.70M -$20.40M -$29.20M
YoY Change -22.46% -30.14% 9.77%
Acquisitions
YoY Change
Other Investing Activities -$34.50M $600.0K $1.600M
YoY Change -7000.0% -62.5% 433.33%
Cash From Investing Activities -$45.20M -$19.80M -$27.60M
YoY Change 242.42% -28.26% 4.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.40M -46.20M -76.20M
YoY Change 62.86% -39.37% -1018.07%
NET CHANGE
Cash From Operating Activities 46.40M 79.30M 58.10M
Cash From Investing Activities -45.20M -19.80M -27.60M
Cash From Financing Activities 11.40M -46.20M -76.20M
Net Change In Cash 12.60M 13.30M -45.70M
YoY Change -13.1% -129.1% -196.41%
FREE CASH FLOW
Cash From Operating Activities $46.40M $79.30M $58.10M
Capital Expenditures -$10.70M -$20.40M -$29.20M
Free Cash Flow $57.10M $99.70M $87.30M
YoY Change 65.51% 14.2% -5.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3937000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4108000 USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51019918 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50607751 shares
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51019918 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50607751 shares
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
263479000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
279154000 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-12-28
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14041
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2882273
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
848-7100
dei Security12b Title
Security12bTitle
Common stock, $.01 par value per share
dei Trading Symbol
TradingSymbol
HAE
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 us-gaap Gross Profit
GrossProfit
128050000 USD
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50298046 shares
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
CY2018Q4 us-gaap Gross Profit
GrossProfit
111175000 USD
us-gaap Gross Profit
GrossProfit
370956000 USD
us-gaap Gross Profit
GrossProfit
306326000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247356000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
718284000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130920000 USD
CY2018Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136181000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
379031000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411958000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7000000 USD
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8978000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21909000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26967000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78267000 USD
CY2018Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73877000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
221106000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
219670000 USD
CY2019Q4 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1876000 USD
CY2018Q4 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
50597000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
87143000 USD
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
82855000 USD
us-gaap Operating Expenses
OperatingExpenses
293612000 USD
us-gaap Operating Expenses
OperatingExpenses
246637000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40907000 USD
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28320000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
77344000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
59689000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3078000 USD
CY2018Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2858000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12152000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7875000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37829000 USD
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25462000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
65192000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
51814000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7934000 USD
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7185000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6290000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17630000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
18277000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
us-gaap Net Income Loss
NetIncomeLoss
34184000 USD
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51401000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51708000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638000 shares
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52822000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51995000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53184000 shares
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32296000 USD
CY2018Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13214000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55577000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24079000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126417000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169351000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170753000 USD
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
185027000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
254167000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
194337000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31238000 USD
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27406000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
582575000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
576121000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
268104000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
343979000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
107307000 USD
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
127693000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
211062000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4428000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
210819000 USD
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
63361000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44425000 USD
CY2019Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4359000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64273000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11796000 USD
CY2019Q4 us-gaap Assets
Assets
1237749000 USD
CY2019Q1 us-gaap Assets
Assets
1274767000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
61966000 USD
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
27666000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52298000 USD
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53200000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
98003000 USD
CY2019Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
91532000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
256692000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
235759000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
309738000 USD
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
322454000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
14576000 USD
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
19906000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
82163000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28780000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
504000 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
510000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
537913000 USD
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
536320000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69868000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
161418000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33705000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30380000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
574580000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
667868000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1237749000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1274767000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
667868000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1830000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3635000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4730000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3618000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
590966000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2410000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2108000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
583754000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1538000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1667000 USD
CY2019Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5325000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2401000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
574580000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
752429000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1780000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2831000 USD
CY2018Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
80000000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3379000 USD
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
1177000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2819000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4719000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
674058000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4295000 USD
CY2018Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4582000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
18726000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-323000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
701339000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1474000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2321000 USD
CY2018Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
80000000 USD
CY2018Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 USD
CY2018Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4782000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
18277000 USD
CY2018Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5063000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
643129000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
us-gaap Net Income Loss
NetIncomeLoss
34184000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
81524000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
79637000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50597000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
21170000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15055000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12743000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-4747000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
12330000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-2246000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
3220000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8083000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1945000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1038000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13807000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19752000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
68251000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11624000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
9102000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
231000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17590000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5928000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111811000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
138643000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38112000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
105245000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9808000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16263000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2314000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12041000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102931000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
30000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0 USD
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
347780000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8750000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
258103000 USD
hae Proceedsfrom Debt Issuance Costs
ProceedsfromDebtIssuanceCosts
-175000000 USD
hae Proceedsfrom Debt Issuance Costs
ProceedsfromDebtIssuanceCosts
-160000000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
3368000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
3254000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7712000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9446000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
90000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142580000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57623000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-124000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3387000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-42934000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-25298000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169351000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180169000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126417000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154871000 USD
us-gaap Interest Paid Net
InterestPaidNet
10739000 USD
us-gaap Interest Paid Net
InterestPaidNet
9492000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9888000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6233000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
10705000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
12100000 USD
CY2019Q4 hae Paymentsto Acquire Operating Lease Rightof Use Assetand Lease Incentive
PaymentstoAcquireOperatingLeaseRightofUseAssetandLeaseIncentive
41826000 USD
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-147000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
2900000 USD
CY2019Q4 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
2400000 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
617000 USD
CY2018Q4 us-gaap Restructuring Charges
RestructuringCharges
-694000 USD
us-gaap Restructuring Charges
RestructuringCharges
2929000 USD
us-gaap Restructuring Charges
RestructuringCharges
-1019000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
617000 USD
CY2018Q4 us-gaap Restructuring Charges
RestructuringCharges
-694000 USD
us-gaap Restructuring Charges
RestructuringCharges
2929000 USD
us-gaap Restructuring Charges
RestructuringCharges
-1019000 USD
CY2019Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
7181000 USD
CY2018Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
2448000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
10653000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
8240000 USD
CY2019Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
7798000 USD
CY2018Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
1754000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
13582000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
7221000 USD
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6300000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.096
CY2019Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3100000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
12400000 USD
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17600000 USD
CY2018Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.282
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.340
CY2018Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1800000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
5800000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
21200000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
18277000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
us-gaap Net Income Loss
NetIncomeLoss
34184000 USD
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51401000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51708000 shares
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
18277000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
us-gaap Net Income Loss
NetIncomeLoss
34184000 USD
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51401000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51708000 shares
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1008000 shares
CY2018Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1421000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1185000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1476000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638000 shares
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52822000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51995000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53184000 shares
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2018Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2019Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
325000000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22100000 USD
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.56
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8000000.0 USD
CY2019Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5600000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17400000 USD
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20300000 USD
CY2019Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3100000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16500000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73834000 USD
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
69420000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11628000 USD
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12610000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
168705000 USD
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
112307000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
254167000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
194337000 USD
CY2019Q4 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
21200000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
210819000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
243000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
40962000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
73396000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13003000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
211062000 USD
CY2019Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54158000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5947000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54446000 USD
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y1M6D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0400
us-gaap Operating Lease Cost
OperatingLeaseCost
3800000 USD
CY2019Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
8400000 USD
CY2019Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1326000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
5160000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1528000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9484000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8322000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7422000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5678000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
60393000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2019Q4 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
257064000 USD
CY2018Q4 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
244923000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
742720000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
707670000 USD
CY2019Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-3291000 USD
CY2018Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-2442000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-8072000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-3323000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247356000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
718284000 USD
CY2019Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
2521000 USD
CY2018Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
2133000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
7791000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
7782000 USD
CY2019Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 USD
CY2018Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
51220000 USD
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
21170000 USD
CY2019Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5772000 USD
CY2018Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
6131000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
17681000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
18667000 USD
CY2019Q4 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
6649000 USD
CY2018Q4 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
4822000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
18708000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
13203000 USD
CY2019Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2018Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8083000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2019Q4 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
7798000 USD
CY2018Q4 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
1791000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
13582000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
7258000 USD
CY2019Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
448000 USD
CY2018Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
0 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
1005000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
0 USD
CY2019Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2018Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1614000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
701000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2289000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40907000 USD
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28320000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
77344000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
59689000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247356000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
718284000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
247356000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
718284000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-30380000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3752000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-427000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3325000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33705000 USD

Files In Submission

Name View Source Status
0000313143-20-000012-index-headers.html Edgar Link pending
0000313143-20-000012-index.html Edgar Link pending
0000313143-20-000012.txt Edgar Link pending
0000313143-20-000012-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hae-20191228.xsd Edgar Link pending
hae-20191228_cal.xml Edgar Link unprocessable
hae-20191228_def.xml Edgar Link unprocessable
hae-20191228_lab.xml Edgar Link unprocessable
hae-20191228_pre.xml Edgar Link unprocessable
haeq3dec2020doc.htm Edgar Link pending
haeq3dec2020doc_htm.xml Edgar Link completed
haeq3dec2020ex311.htm Edgar Link pending
haeq3dec2020ex312.htm Edgar Link pending
haeq3dec2020ex321.htm Edgar Link pending
haeq3dec2020ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending